Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Did you ever feel your own shoulders relax when you saw a friend receive a shoulder massage? For those of you who said "yes," congratulations, your brain is using its power to create a "placebo effect." For those who said "no," you're not alone, but thankfully, the brain is trainable. Since the 1800s, the word placebo has been used to refer to a fake treatment, meaning one that does not contain any active, physical substance. Today, placebos play a crucial role in medical studies in which some participants are given the treatment containing the active ingredients of the medicine, and others are given a placebo. These types of studies help tell researchers which medicines are effective, and how effective they are. Surprisingly, however, in some areas of medicine, placebos themselves provide patients with clinical improvement. Research suggests that the placebo effect is caused by positive expectations, the provider-patient relationship and the rituals around receiving medical care. Depression, pain, fatigue, allergies, irritable bowel syndrome, Parkinson's disease and even osteoarthritis of the knee are just a few of the conditions that respond positively to placebos. In addition to the ever-increasing body of evidence surrounding their effectiveness, placebos offer multiple benefits. They have no side effects. They are cheap. They are not addictive. They provide hope when there might not be a specific chemically active treatment available. They mobilize a person's own ability to heal through multiple pathways.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Like many paediatricians, Dani Dumitriu braced herself for the impact of the SARS-CoV-2 coronavirus when it first surged in her wards. She was relieved when most newborn babies at her hospital who had been exposed to COVID-19 seemed to do just fine. But hints of a more subtle and insidious trend followed close behind. Dumitriu and her team ... had more than two years of data on infant development – since late 2017, they had been analysing the communication and motor skills of babies up to six months old. Dumitriu thought it would be interesting to compare the results from babies born before and during the pandemic. The infants born during the pandemic scored lower, on average, on tests of gross motor, fine motor and communication skills compared with those born before it. It didn't matter whether their birth parent had been infected with the virus or not; there seemed to be something about the environment of the pandemic itself. Lockdowns ... have isolated many young families, robbing them of playtime and social interactions. Stressed out and stretched thin, many carers also haven't been able to provide the one-to-one time that babies and toddlers need. Worryingly, [biophysicist Sean] Deoni has found that the longer the pandemic has continued, the more deficits children have accumulated. "The magnitude is massive – it's just astonishing," Deoni says of the findings, which are now under revision in JAMA Pediatrics.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Inspired by a parasitic worm that digs its sharp teeth into its host's intestines, Johns Hopkins researchers have designed tiny, star-shaped microdevices that can latch onto intestinal mucosa and release drugs into the body. David Gracias, a professor in the Whiting School of Engineering, and gastroenterologist Florin M. Selaru, director of the Johns Hopkins Inflammatory Bowel Disease Center, led a team of researchers and biomedical engineers that designed and tested shape-changing microdevices that mimic the way the parasitic hookworm affixes itself to an organism's intestines. The "theragrippers" are made of metal and a thin, shape-changing film, then coated in heat-sensitive paraffin wax. The devices, each roughly the size of a dust speck, can potentially carry any drug and release it gradually into the body. Thousands of theragrippers can be deployed in the GI tract. When the paraffin wax coating on the grippers reaches the temperature inside the body, the devices close autonomously and clamp onto the colonic wall. The closing action causes the tiny, six-pointed devices to dig into the mucosa and remain attached to the colon, where they are retained and release their medicine payloads gradually into the body. Theragrippers, says Gracias, don't rely on electricity, wireless signals or external controls. "Instead, they operate like small, compressed springs with a temperature-triggered coating on the devices that releases the stored energy autonomously."

Note: These tiny devices are literally the size of a speck of dust. They can easily be hidden in a cotton swab and administered without a person's knowledge. Might they even be put in a vaccine and go undetected? For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

COVID-19 is a global pandemic. Treatment with hydroxychloroquine (HCQ), zinc, and azithromycin (AZM), also known as the Zelenko protocol, and treatment with intravenous (IV) vitamin C (IVC) have shown encouraging results in a large number of trials worldwide. In addition, vitamin D levels are an important indicator of the severity of symptoms in patients with COVID-19. Hospitalized patients with COVID-19 ... were screened for eligibility and randomly allocated to receive either HCQ, AZM, and zinc (group 1) or HCQ, AZM, zinc plus IV vitamin C treatment (group 2) for 14 days. The patients also received nontherapeutic levels of vitamin D3. A total of 237 hospitalized patients with COVID-19 ... were enrolled in the study. Almost all patients were vitamin D deficient (97%). All but one patient (99.6%; n = 236/237) treated with HCQ, AZM, and zinc with or without high-dose IV vitamin C (IVC) fully recovered. Additional IVC therapy contributed significantly to a quicker recovery (15 days versus 45 days until discharge; p = 0.0069). Low vitamin D levels were significantly correlated with a higher probability of admission to the intensive care unit (ICU) and longer hospital stay. Our study suggests that the treatment protocol of HCQ, AZM, and zinc with or without vitamin C is safe and effective in the treatment of COVID-19, with high dose IV vitamin C leading to a significantly quicker recovery.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Massachusetts health officials on Tuesday reported ... 290 more deaths in people with breakthrough cases. In the last week, 27,530 new breakthrough cases - infections in people who have been vaccinated - were reported, with 555 more vaccinated people hospitalized over the period. It's a 40% drop in the rate of new breakthrough cases in Massachusetts - the previous week saw 46,092 new COVID infections in vaccinated people. On Tuesday ... there were 127 new deaths reported -- a statistic that includes three days because of the weekend -- bringing the death toll to 21,546. The seven-day average test positivity stands at 7.13%. In December, Massachusetts Department of Public Health officials released a study that found that 97% of breakthrough cases in the state did not become severely ill and rarely led to deaths, especially among young people. Massachusetts' COVID metrics, tracked on the Department of Public Health's interactive coronavirus dashboard, have been trending downward after spiking to heights not seen since previous surges, a peak thought to be driven at least in part by the omicron variant.

Note: As of Jan. 31, 2022, Massachusetts had a total of 21,546 COVID deaths as reported above. Their first COVID death was on Mar. 20, 2020. So over the 97 weeks since the start of the pandemic, they averaged 222 deaths a week. Yet in the last week of January 2022, this NBC article reports 290 breakthrough deaths. So the number of deaths among the vaccinated in that one week was greater than the average weekly number of deaths for the whole pandemic. Weren't these vaccines supposed to be 90% effective or more?

In May, a long-awaited randomized, double-blind, placebo-controlled, Phase 3 clinical trial testing MDMA-assisted therapy for the treatment of PTSD was published in Nature Medicine. The trial was conducted by MAPS Public Benefit Corporation, a for-profit subsidiary launched by the registered non-profit in 2014, with the goal of conducting the necessary research to make MDMA a legally available medicine. "We are a for-profit, but we're wholly owned. We only have one shareholder, and it's a non-profit," says CEO Amy Emerson. While a non-profit is tax exempt and operates for charity, the PBC, like a traditional corporation, pays taxes, operates for profit, and has shareholders and stocks. The results of the Phase 3 clinical trial conducted by MAPS PBC revealed that after receiving a combination of talk therapy and MDMA, 67 percent of participants who received the drug no longer met the diagnostic criteria for PTSD, compared to 32 percent of participants who received the placebo. The trial was recently acknowledged as a "big win for the field" in Science Magazine's annual Breakthrough of the Year awards. "In our three-session model, there's no follow-up medication needed," [MAPS CMO Dr. Corine de Boer] says. After pooling the data of six Phase 2 trials together, de Boer's team found that 57 percent of participants no longer met the criteria for PTSD. At a one-year follow-up during which no MDMA was administered, that number increased to 67 percent.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.

McMaster Children's Hospital says it has seen a steady increase of youth in crisis since the COVID-19 pandemic began. Youth admitted for medical support after a suicide attempt has tripled over a four-month period, compared to last year. The hospital also said that patients are staying in hospital longer due to more serious attempts. A large number of these youth have reported COVID-related issues such as lack of social interaction, increased conflict at home, and the inability to rely on friends as main contributors. Over the same time period, youth admitted with substance use disorders has doubled compared to last year. In particular, the use of potentially deadly opioids has increased. The number of cases admitted to hospital with predominant symptoms of psychosis has doubled, with the large majority related to substance use. Meanwhile, McMaster Children's Hospital says referrals to its Eating Disorders Program have increased by 90 per cent in a four-month period, compared to last year. Admissions are projected to increase by 33 per cent over the 12-months since the pandemic started. "It's unprecedented," says clinical manager Paul Agar.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

European Union regulators warned that frequent Covid-19 booster shots could adversely affect the immune response and may not be feasible. Repeat booster doses every four months could eventually weaken the immune response and tire out people, according to the European Medicines Agency. Instead, countries should leave more time between booster programs and tie them to the onset of the cold season in each hemisphere, following the blueprint set out by influenza vaccination strategies, the agency said. The advice comes as some countries consider the possibility of offering people second booster shots in a bid to provide further protection against surging omicron infections. Earlier this month Israel became the first nation to start administering a second booster, or fourth shot, to those over 60. The U.K. has said that boosters are providing good levels of protection and there is no need for a second booster shot at the moment, but will review data as it evolves. Boosters "can be done once, or maybe twice, but it's not something that we can think should be repeated constantly," Marco Cavaleri, the EMA head of biological health threats and vaccines strategy, said at a press briefing on Tuesday. "We need to think about how we can transition from the current pandemic setting to a more endemic setting."

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Pregnant women have long been assured that acetaminophen can treat their aches, pains and fevers without bringing harm to the babies they carry. Now researchers say they have found a strong link between prenatal use of the medication and cases of attention-deficit hyperactivity disorder in children. The results, published ... in the journal JAMA Pediatrics, add to growing evidence that the active ingredient in Tylenol may influence brain development in utero. But they do not provide clear answers for mothers-to-be or their doctors about whether acetaminophen is safe during pregnancy. In analyzing data on more than 64,000 Danish women and their children, researchers found that kids whose mothers took the painkiller at any point during pregnancy were 29% more likely to be diagnosed with ADHD than were kids whose mothers took none. The risk increased the most – by 63% – when acetaminophen was taken during the second and third trimesters, and by 28% when used in the third trimester alone. But when taken only in the first trimester, the added risk was 9%. Members of the research team had long suspected that acetaminophen may behave as an endocrine-disrupting chemical capable of influencing fetal brain development. The drug is known to cross the placental barrier between mother and fetus, and some studies have found higher rates of male babies with undescended testicles born to women who took it during pregnancy.

Note: Another study on Tylenol found a two-fold increase in risk of children being born with both ADHD and autism. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

After 30 years of immunology research, [Louis Picker] is on the verge of launching human trials for a vaccine that could stop AIDS, an epidemic that has become something of an afterthought decades after it began ravaging gay men in America. For many in the developed world, complacency has set in, largely thanks to a regimen of antiretroviral drugs that allow people with HIV to live long and healthy lives, and decades of failed attempts to develop a vaccine. In 1984, U.S. Secretary of Health and Human Services Margaret Heckler expressed hope ... that science might have a vaccine for HIV within two years. Instead, a decade passed, and by 1994, AIDS was the leading cause of death for Americans ages 25 to 44. Four vaccines have made it to human trials, but none made it to market. As Picker continued his research, scientists developed a series of antiretroviral drugs that slowly downgraded HIV to a chronic disease ... in the developed world. But globally, AIDS is still killing a lot of people, largely because most of those infected in poorer countries don't have access to the drugs. According to the World Health Organization, 1.1 million people died from AIDS in 2015. In the U.S., 50,000 new cases of HIV are reported every year. Worldwide, the number is 2 million. Every time news reports come out about Picker's research, he fields a series of phone calls from HIV-infected patients, their friends and their family. "Can I be in your trial?" people ask him. "Please, can you save my son?"

Note: How is it that COVID-19 vaccines were created just months after it became a threat while many decades later no vaccine has been found for the deadly AIDS epidemic, which according to the WHO has killed 36 million - many times the number of deaths from COVID? For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

A year ago, just two doses of a Covid-19 vaccine – or even one, in the case of Johnson & Johnson's formulation – were thought to offer sufficient protection against the coronavirus. On Wednesday, the Centers for Disease Control and Prevention expanded eligibility for boosters to adolescents and backed away from describing anyone as "fully vaccinated" because two shots no longer seem adequate. Instead, one's vaccination status will now be "up to date" – or not. It's no surprise that many Americans are wondering: Where does this end? Are we to roll up our sleeves for booster shots every few months? Scientists are reluctant to predict the future. But in interviews this week, nearly a dozen said that whatever happens, trying to boost the entire population every few months is not realistic. Nor does it make much scientific sense. For starters, persuading people to line up for shots every few months is probably a losing proposition. Just as important, there are no data to support the effectiveness of a fourth dose of the current vaccines. If the coronavirus settles into a flulike seasonal pattern, as it seems possible, "you can imagine a scenario where we simply give boosters before the winter each year," Dr. Hensley said. Lessons from flu season also suggest that frequent vaccination is unlikely to be helpful. Giving the flu vaccine twice a year "has a diminishing return, and so it may not make sense to do vaccination so frequently," said [epidemiologist] Ben Cowling.

Note: Could it be that this is what big Pharma has been hoping for all along - forever boosting? And if it's all free, you won't even see how billions of your tax dollars are flowing into the pockets of the elite. Could this be why the Australian government on their website stated they are securing 195 million doses of COVID vaccine boosters for their population of 25 million? For more, see this revealing article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Psychedelics startups don't just want to just reinvent mental health. They also want to reinvent capitalism. And judging by the news coming out of last week's "Horizons: Perspectives on Psychedelics" conference in Manhattan, they're having some early success. Stephen Jurvetson, co-founder of Future Ventures and a board member at SpaceX, told me ... that he's a true believer in the industry's mission to fix the state of mental-health care. He decided last week to carve up his own estate by giving around half of his net worth to fund psychedelic science. Organizations like the public-benefit corporation of Multidisciplinary Association for Psychedelics Studies, or MAPS, and the Psychedelic Science Funders Collaborative, a nonprofit organization, have both accepted charitable donations but fund research that could lead to blockbuster drugs. Psychedelics startups do need funding, and badly. Like biotech, it's a high-risk industry with expensive clinical trials and regulatory uncertainty. And patents, a traditional financial engine for biotech, are harder to win for plants that have been around for centuries, or molecules that have already made the rounds as street drugs. MAPS also made a major announcement: The New York-based venture capital fund Vine Ventures has created a $70 million special purpose vehicle to fund its Phase 3 clinical trials on post-traumatic stress disorder and MDMA. The novel funding method ... will help keep MAPS a nonprofit while letting it retain control of its intellectual property.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.

Legal psychedelic medicine is poised to soon disrupt the multibillion-dollar mental health field. Treatments being trialed today in clinical settings using substances like psilocybin-containing mushrooms will soon offer legal alternatives to the more than 50 percent of patients receiving therapy for major depressive disorder (MDD) who do not respond to approved depression medications. The creation of new effective therapies will likely put pressure on healthcare providers to examine the upside of psychedelic therapies and how such treatments will inevitably affect their bottom line. While these therapies will not be a cure-all for everyone, over the next three to five years an expanding number of psychedelic treatments will produce alternatives for the many patients who find no relief from FDA-approved, first-line therapeutics like selective serotonin reuptake inhibitors (SSRIs). Since legalizing the use of psilocybin-containing magic mushrooms in 2020 through a ballot measure, Oregon is now in the process of creating an intricate statewide system for qualified caregivers to deliver psilocybin treatments in therapeutic settings. Sessions using psilocybin can last over six hours, which does not include vital therapy before and after treatments. MDMA-assisted therapy for severe post-traumatic stress disorder (PTSD), which is very close to being an FDA-approved therapy, will likewise require significant clinician involvement before, during and after a session.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.

Existing surveillance studies are not designed to reliably estimate life-threatening event or vaccine-induced fatality rates (VFR). Here, regional variation in vaccination rates was used to predict all-cause mortality and non-COVID deaths in subsequent time periods using two independent, publicly available datasets from the US and Europe. Results [suggest] 146K to 187K vaccine-associated US deaths between February and August, 2021. Comparing our estimate with the CDC-reported VFR (0.002%) suggests VAERS deaths are underreported by a factor of 20, consistent with known VAERS under-ascertainment bias. Comparing our age-stratified VFRs with published age-stratified coronavirus infection fatality rates (IFR) suggests the risks of COVID vaccines and boosters outweigh the benefits in children, young adults, and older adults with low occupational risk or previous coronavirus exposure. There is little to no evidence that vaccines reduce community spread and transmission. Vaccine mandates in workplaces, colleges, schools and elsewhere are ill-advised. The mandates are not based on sound science given the relatively low COVID risk in healthy middle-aged and young adults and growing evidence base for alternative prevention and early treatment options for COVID.

Note: See this webpage for information on the author of this study. Why has the media been all but silent on deaths and injuries from the vaccines? Read hundreds of personal stories of severe vaccine injury and death that are not being reported. And explore an excellent website which presents official VAERS information and in easily understandable format. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Arpad Pusztai spoke for only two and a half minutes during his interview for ITN's World in Action in 1998, but it was enough to end his career. The Hungarian-born expert in lectins, a type of protein, had spent decades working at the Rowett Institute in Aberdeen and had almost 300 scientific papers and three books to his name. In the mid-1990s, with big food manufacturers increasingly developing and promoting genetically modified crops, he had been asked to investigate the effect that their products, specifically GM potatoes, could have on rats. His data showed that those being fed GM potatoes experienced stunted organ and brain growth and disturbance to their immune systems. Pusztai ... agreed to discuss his research on television in the hope of attracting new funding. His comments, which were promoted by the programme in a press release headed "new health fears over 'Frankenstein' food", started a media frenzy. Pusztai was suspended and his raw data was seized. According to [author Andrew] Rowell: "All GM work was stopped immediately and Pusztai's team was dispersed. His three PhD students were moved to other areas. He was threatened with legal action if he spoke to anyone. His phone calls and emails were diverted. No one was allowed to speak to him either." In Pusztai's telling ... the Rowett Institute came under pressure from senior figures in the government and the food industry. Two employees told him that the institute had taken calls from the office of Tony Blair, the prime minister.

Note: Read more about this important scientist. And for more on the dangers of GM food, see this important book summary. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and GMOs from reliable major media sources.

Drug makers and other healthcare companies spent almost $30 billion in a single year to influence the medical choices made by Americans and steer them toward treatments that were newer, vastly more expensive and sometimes riskier than their tried-and-true alternatives, new research shows. The 2016 expenditures paid for TV commercials, sponsorships of patients' groups, promotional meetings for doctors, free drug samples and perks for prescribers. The amount represents a 70% increase since 1997, when drug companies began making direct appeals to American consumers. The study ... offers the most comprehensive accounting of healthcare marketing efforts to date. It traces broad shifts in the media and regulatory environment in which health companies operate, as well as the drugs and services – including erectile dysfunction pills, DNA testing kits and robotic surgery services – they are keen to sell. While lawmakers and regulators have tried to counter the impact of healthcare marketing in recent years, the reforms have had little effect on an industry that accounts for nearly 18% of the country's gross domestic product. The drug industry has increasingly turned to a more indirect approach in its marketing: sponsoring disease-awareness campaigns. Such campaigns, in which a company sponsors ads that do not name a particular medication, rose from 44 in 1997 to 401 in 2016, with an attendant spending increase from $177 million to $430 million.

Note: The pharmaceutical industry provides 75% of television advertising revenue when many countries do not allow drug advertising. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.

High COVID-19 vaccination rates were expected to reduce transmission of SARS-CoV-2 in populations by reducing the number of possible sources for transmission and thereby to reduce the burden of COVID-19 disease. Recent data, however, indicate that the epidemiological relevance of COVID-19 vaccinated individuals is increasing. In the UK it was described that secondary attack rates among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% for vaccinated vs 23% for unvaccinated). 12 of 31 infections in fully vaccinated household contacts (39%) arose from fully vaccinated epidemiologically linked index cases. Between week 39 and 42, a total of 100.160 COVID-19 cases were reported among citizens of 60 years or older. 89.821 occurred among the fully vaccinated (89.7%), 3.395 among the unvaccinated (3.4%). One week before, the COVID-19 case rate per 100.000 was higher among the subgroup of the vaccinated compared to the subgroup of the unvaccinated. The [CDC] identifies four of the top five counties with the highest percentage of fully vaccinated population (99.9–84.3%) as "high" transmission counties. It appears to be grossly negligent to ignore the vaccinated population as a possible and relevant source of transmission.

Note: This paper in the UK's highly esteemed Lancet shows that the vaccines are not stopping the spread of infection of COVID. They clearly are greatly decreasing the number of hospitalizations and deaths among the vaccinated, but they are not helping to stop the spread of this virus. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Laurie Valeriano first heard about DINP decades ago. "I started to worry about the chemicals that come out of all these plastics," she said. DINP, one of a group of chemicals called phthalates that makes plastic more pliable, was one of them. It was already clear that DINP could cause cancer and interfere with hormonal functioning. In February 2000, Valeriano and her employer, the Washington Toxics Coalition, asked the Environmental Protection Agency to add DINP to the list of chemicals it monitors through a nationwide program called the Toxics Release Inventory. Seven months later ... the EPA announced that it planned to grant the group's request and issued a proposed rule that would add DINP to the toxics inventory. Yet more than 20 years later, the EPA has yet to make good on its promise to add DINP to the list of chemicals. It never finalized the rule. Companies have continued to churn out DINP ... in astounding amounts without disclosing how much individual plants make and emit. In addition to the cancer and hormone disruption that sparked Valeriano's claim 21 years ago, we now know more about how DINP affects the sexual development of children. It decreases sperm motility, increases malformations of the testes and other organs, and makes boys ... more likely to be infertile later in life. In fact, the entire group of phthalates – an estimated half-billion pounds of which are made and used in the U.S. each year – seem to cause a similar constellation of health problems.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health from reliable major media sources.

Dr. Anthony Fauci is rewriting history. He is doing so to disguise his shameful role in delaying promotion of an AIDS treatment that would have prevented tens of thousands of deaths in the first years of the epidemic. In my book, Body Counts, A Memoir of Politics, Sex, AIDS, and Survival, I recount how slow the federal government was in publicizing the use of Bactrim and other sulfa drugs to prevent PCP (the pneumonia that was then the leading killer of people with AIDS). Had Fauci listened to people with AIDS and the clinicians treating them, and responded accordingly, he would have saved thousands of lives. Between 1987, when [AIDS activist Michael] Callen met with Fauci and 1989, when the guidelines were ultimately issued, nearly 17,000 people with AIDS suffocated from PCP. Most of these people might have lived had Fauci responded appropriately. Callen and others ... met with Fauci to plead for his support. They explained that many frontline AIDS physicians, following the lead of Dr. Joseph Sonnabend, were already using Bactrim effectively to prevent the recurrence of PCP. The science was clear. Fauci refused to acknowledge the evidence and, according to one account, even encouraged people with AIDS to stop taking treatments, like Bactrim. Treatment activist Richard Jefferys wrote in 2001 that Fauci "went as far as telling activists attending a 1987 meeting that there was no data to suggest PCP prophylaxis was beneficial and that it may, in fact be dangerous."

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health from reliable major media sources.

In his new bestselling book The Real Anthony Fauci: Bill Gates, Big Pharma and the Global War on Democracy and Public Health, Children's Health Defense board chair and lead counsel Robert F. Kennedy, Jr. provides readers with previously little-known information on Dr. Fauci's handling of pandemics prior to COVID including the AIDS epidemic. "...Dr. Fauci copied the choreographed script for winning remdesivir's EUA from the worn rabbit-eared playbook that he developed during his early AIDS years, and then used repeatedly across his career to win approvals for deadly and ineffective drugs," writes Kennedy. "Time and again, he has terminated clinical trials of his sweetheart drugs the moment they begin to reveal cataclysmic toxicity. He makes the absurd claim that his drug-du-jour had proven so miraculously effective that it would be unethical to deny it to the public, and then he strong-arms FDA to grant his approvals." One of the AIDS treatments promoted by Dr. Fauci and his agency [NIAID] was azidothymidine (AZT), a powerful and toxic chemotherapy drug used widely for AIDS patients despite the availability of less toxic options. AZT, according to SPIN magazine, is a drug that "was worse than the disease." Kennedy also exposes Dr. Fauci's experiments using various toxic AIDS drugs on Black and Hispanic foster children in New York and six other states.

Note: Read more about the foster children used as guinea pigs to test HIV drugs. If you don't have time for the whole book (rated 4.9 stars on amazon.com), you can find an engaging summary of key points on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.